Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
Citation
Hwang , E C , Gandhi , S , Jung , J H , Imamura , M , Kim , M H , Pang , R & Dahm , P 2018 , ' Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia ' , Cochrane Database of Systematic Reviews , no. 10 , CD007360 . https://doi.org/10.1002/14651858.CD007360.pub3
Rights
This is the peer reviewed version of the following article:Hwang EC, Gandhi S, Jung JH, Imamura M, Kim MH, Pang R, Dahm P. Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD007360., which has been published in final form at DOI: 10.1002/14651858.CD007360.pub3. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions